BMAL1 and type 2 diabetes mellitus: These results suggest that inhibition of CLOCK/BMAL1 results in an increase in the level of interaction between THP-1 cells and the HUVEC monolayer, similar to the enhanced interactions shown for cells from our participants with type 2 diabetes.